Level up your trading with our powerful tools and real-time insights all in one place.
The current TSMRF market cap is 2.15B. The company's latest EPS is JPY 218.3711 and P/E is 0.13.
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
| Total Revenue | 123.25B | 130.88B | 129.55B | 140.04B | 150.85B |
| Operating Income | 18.97B | 19.5B | 22.38B | 20.32B | 20.02B |
| Net Income | 13.77B | 15.33B | 18.84B | 16.48B | 16.71B |
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
| Total Assets | 311.04B | 319.06B | 350.98B | 396.81B | 428.25B |
| Total Liabilities | 97.99B | 85.89B | 92.87B | 124.57B | 132.89B |
| Total Equity | 213.05B | 233.17B | 258.11B | 272.25B | 295.37B |
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
| Operating | 18.19B | 16.1B | 21.31B | 16.45B | 5.61B |
| Investing | -23.49B | -7.35B | -9.11B | -15.49B | -19.35B |
| Financing | 7.11B | -10.43B | -8.18B | 24.42B | -4.42B |
| Market Cap | 2.15B |
| Price to Earnings Ratio | 0.13 |
| Price to Sales Ratio | 0.01 |
| Price to Cash Ratio | 0.03 |
| Price to Book Ratio | 0.01 |
| Dividend Yield | 36,210.30% |
| Shares Outstanding | 76.51M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | 50.13% |
| 52 Week High | 28.15 |
| 52 Week Low | 18.75 |
| Spread (Intraday) | 2.8 (8.25%) |
| Company Name | Tsumura and Company (PK) |
| Address |
2-17-11 akasaka minato, tokyo 107-8521 |
| Website | https://www.tsumura.co.jp |
| Industry | drugs-health r&d/testing labs (H8) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
